Fei-Yun Wu Selected Research

Graves Ophthalmopathy

1/2024	Altered Static and Dynamic Brain Functional Topological Organization in Patients with Dysthyroid Optic Neuropathy.
1/2024	Diagnosis of dysthyroid optic neuropathy: combined value of orbital MRI and intracranial visual pathway diffusion kurtosis imaging.
11/2023	Altered dynamic brain activity and functional connectivity in thyroid-associated ophthalmopathy.
10/2023	Structural and Functional Brain Changes After Glucocorticoid Therapy in Thyroid-Associated Ophthalmopathy.
1/2023	Increased brain iron in patients with thyroid-associated ophthalmopathy: a whole-brain analysis.
1/2023	Altered neurovascular coupling in thyroid-associated ophthalmopathy: A combined resting-state fMRI and arterial spin labeling study.
10/2022	Reduced cortical complexity in patients with thyroid-associated ophthalmopathy.
6/2022	Multiparametric magnetic resonance imaging for differentiating active from inactive thyroid-associated ophthalmopathy: Added value from magnetization transfer imaging.
1/2022	T2 -Weighted MR Imaging-Derived Radiomics for Pretreatment Determination of Therapeutic Response to Glucocorticoid in Patients With Thyroid-Associated Ophthalmopathy: Comparison With Semiquantitative Evaluation.
1/2022	Altered Long- and Short-Range Functional Connectivity Density in Patients With Thyroid-Associated Ophthalmopathy: A Resting-State fMRI Study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fei-Yun Wu Research Topics

Disease

21	Graves Ophthalmopathy 01/2024 - 01/2020
12	Ischemic Stroke 12/2023 - 09/2019
11	Stroke (Strokes) 12/2023 - 09/2019
4	Infarction (Infarctions) 03/2023 - 08/2022
3	Papillary Thyroid Cancer 08/2023 - 11/2020
3	Neoplasms (Cancer) 07/2023 - 08/2018
2	Optic Nerve Diseases (Optic Neuropathy) 01/2024 - 03/2021
2	Neoplasm Metastasis (Metastasis) 08/2023 - 11/2020
2	Lymphatic Metastasis 08/2023 - 01/2022
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 08/2023 - 01/2021
1	Leukoaraiosis 01/2023
1	Tics (Tic) 01/2023
1	Fibrosis (Cirrhosis) 12/2021
1	Exophthalmos (Proptosis) 03/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Cognitive Dysfunction 01/2021
1	Thyroid Neoplasms (Thyroid Cancer) 02/2018
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2018
1	Sensorineural Hearing Loss 01/2015
1	Type 2 Diabetes Mellitus (MODY) 01/2012

Drug/Important Bio-Agent (IBA)

21	Troleandomycin (TAO)FDA Link 01/2024 - 01/2020
10	Cytidine Triphosphate (CTP)IBA 12/2023 - 09/2019
4	GlucocorticoidsIBA 10/2023 - 11/2020
4	IodineIBA 07/2023 - 11/2020
3	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2018
2	salicylhydroxamic acid (SHAM)IBA 08/2023 - 01/2021
2	Contrast MediaIBA 08/2023 - 01/2021
2	GadoliniumIBA 08/2023 - 01/2021
1	allogenic effect factor (AEF)IBA 08/2023
1	Complement System Proteins (Complement)IBA 08/2023
1	IronIBA 01/2023
1	Hematoxylin (Haematoxylon)IBA 12/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Adenosine Diphosphate (ADP)IBA 01/2012
1	Adenosine Triphosphate (ATP)IBA 01/2012

Therapy/Procedure

7	Therapeutics 10/2023 - 02/2018
6	Thrombectomy 09/2023 - 01/2021
1	Cochlear Implantation 01/2015